E
Zentalis Pharmaceuticals, Inc. ZNTL
$1.63 -$0.12-6.86% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -26.87M -48.28M -94.97M -40.16M -88.28M
Total Depreciation and Amortization 160.00K 262.00K 317.00K 321.00K 327.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 334.00K 13.63M 29.09M 3.05M 39.48M
Change in Net Operating Assets -8.33M 1.75M -7.08M -7.26M 13.33M
Cash from Operations -34.71M -32.64M -39.70M -44.05M -35.14M
Capital Expenditure -- -- 0.00 0.00 -181.00K
Sale of Property, Plant, and Equipment 564.00K 5.00K 0.00 0.00 65.00K
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 29.81M 40.47M 32.28M 48.24M 34.61M
Cash from Investing 30.38M 40.48M 32.28M 48.24M 34.49M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 0.00 189.00K 0.00 92.00K 9.00K
Repurchase of Common Stock -- -- 0.00 0.00 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 0.00 189.00K 0.00 92.00K 9.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -4.33M 8.03M -7.42M 4.29M -640.00K